Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrizia Ferrera

Showing results (71-80 of 92) with videos related to

Pageof 10
Sort By:
The Clinical Journal of Pain|April 19, 2012
The effects of low doses of pregabalin on morphine analgesia in advanced cancer patientsSebastiano Mercadante, Giampiero Porzio, Federica Aielli, et al.
Cancers|April 3, 2021
The Prevalence and Characteristics of Breakthrough Cancer Pain in Patients Receiving Low Doses of Opioids for Background PainSebastiano Mercadante, Marco Maltoni, Domenico Russo, et al.
Current Medical Research and Opinion|October 13, 2012
Tapentadol in cancer pain management: a prospective open-label studySebastiano Mercadante, Giampiero Porzio, Patrizia Ferrera, et al.
Clinical Therapeutics|November 20, 2009
Low doses of transdermal buprenorphine in opioid-naive patients with cancer pain: a 4-week, nonrandomized, open-label, uncontrolled observational studySebastiano Mercadante, Gianpiero Porzio, Patrizia Ferrera, et al.
European Journal of Cancer (Oxford, England : 1990)|January 25, 2011
Does pain intensity predict a poor opioid response in cancer patients?Sebastiano Mercadante, Vittorio Gebbia, Fabrizio David, et al.
The Journal of Pain|February 24, 2009
Tools for identifying cancer pain of predominantly neuropathic origin and opioid responsiveness in cancer patientsSebastiano Mercadante, Vittorio Gebbia, Fabrizio David, et al.
Oncology|August 21, 2002
Pegylated liposomal doxorubicin with vinorelbine in metastatic breast carcinoma. A phase I-II clinical investigationVittorio Gebbia, Gaetano Mauceri, Giuseppina Fallica, et al.
Journal of Pain and Symptom Management|March 28, 2006
Low morphine doses in opioid-naive cancer patients with painSebastiano Mercadante, Gianpiero Porzio, Patrizia Ferrera, et al.
Internal and Emergency Medicine|April 20, 2026
Response to dual anti-impulse and lipid-lowering therapy is associated with clinical outcomes in chronic type B aortic syndromePaolo Bima, Patrizia Ferrera, Elvira Fanelli, et al.
Breast Cancer Research and Treatment|February 27, 2003
Phase I-II parallel study of docetaxel on a bimonthly schedule in refractory metastatic breast carcinomaVittorio Gebbia, Nicolò Borsellino, Antonio Testa, et al.
Pageof 10

Showing results (71-80 of 92) with videos related to

Sort By:
Pageof 10
The Clinical Journal of Pain|April 19, 2012
The effects of low doses of pregabalin on morphine analgesia in advanced cancer patientsSebastiano Mercadante, Giampiero Porzio, Federica Aielli, et al.
Cancers|April 3, 2021
The Prevalence and Characteristics of Breakthrough Cancer Pain in Patients Receiving Low Doses of Opioids for Background PainSebastiano Mercadante, Marco Maltoni, Domenico Russo, et al.
Current Medical Research and Opinion|October 13, 2012
Tapentadol in cancer pain management: a prospective open-label studySebastiano Mercadante, Giampiero Porzio, Patrizia Ferrera, et al.
Clinical Therapeutics|November 20, 2009
Low doses of transdermal buprenorphine in opioid-naive patients with cancer pain: a 4-week, nonrandomized, open-label, uncontrolled observational studySebastiano Mercadante, Gianpiero Porzio, Patrizia Ferrera, et al.
European Journal of Cancer (Oxford, England : 1990)|January 25, 2011
Does pain intensity predict a poor opioid response in cancer patients?Sebastiano Mercadante, Vittorio Gebbia, Fabrizio David, et al.
The Journal of Pain|February 24, 2009
Tools for identifying cancer pain of predominantly neuropathic origin and opioid responsiveness in cancer patientsSebastiano Mercadante, Vittorio Gebbia, Fabrizio David, et al.
Oncology|August 21, 2002
Pegylated liposomal doxorubicin with vinorelbine in metastatic breast carcinoma. A phase I-II clinical investigationVittorio Gebbia, Gaetano Mauceri, Giuseppina Fallica, et al.
Journal of Pain and Symptom Management|March 28, 2006
Low morphine doses in opioid-naive cancer patients with painSebastiano Mercadante, Gianpiero Porzio, Patrizia Ferrera, et al.
Internal and Emergency Medicine|April 20, 2026
Response to dual anti-impulse and lipid-lowering therapy is associated with clinical outcomes in chronic type B aortic syndromePaolo Bima, Patrizia Ferrera, Elvira Fanelli, et al.
Breast Cancer Research and Treatment|February 27, 2003
Phase I-II parallel study of docetaxel on a bimonthly schedule in refractory metastatic breast carcinomaVittorio Gebbia, Nicolò Borsellino, Antonio Testa, et al.
Pageof 10